Flybridge Capital Partners is an early-stage venture capital firm whose mission is to assist talented entrepreneurs in growing innovative, global companies. With $560 million under management, the firm is focused on investing in consumer, energy, healthcare and information technology markets and is led by a team with domain expertise and more than half a century of combined experience in venture capital. For more information, visit www.flybridge.com

Atlas Venture is a leading early-stage venture capital firm that invests in technology and life sciences companies. Since inception in 1980, we have helped build over 300 companies in more than 16 different countries. In the past decade, 48 portfolio companies have been acquired and 47 are now public companies with an aggregate market capitalization of over $15 billion. The firm is currently investing from its seventh fund and manages over $2.5 billion in committed capital. For more information, please visit www.atlasventure.com

General Catalyst Partners is a venture capital and private equity firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead innovation and transform industries. Founded in 2000, General Catalyst Partners leverages its principals' extensive operational, business development and technological expertise to provide portfolio companies with a catalyst for success through business-building and partnership development assistance. General Catalyst is headquartered in Cambridge, Mass. For more information, please visit: www.generalcatalyst.com

Bruce Booth, partner, Atlas Venture
Thomas Hughes, president and CEO, Zafgen
Mike Gilman, founder and CEO, Stromedix
Duncan Greenhalgh, partner, Goodwin Procter
Peter Mueller, EVP Drug Innovation and Realization and chief scientific officer, Vertex
Vicki Sato, board director, Bristol Meyers-Squibb
Michael Taylor, CEO, Ensemble Discovery

Sameer Bharadwaj, general manager, Cabot Elastomer Composites, Cabot Corporation
David Danielson, senior associate, General Catalyst Partners
Richard Eno, president and CEO, Metabolix
Udi Meirav, CEO, Luminus Devices
Hemant Taneja, managing director, General Catalyst Partners
Don Young, president and CEO, Aspen Aerogels
Bilal Zuberi, principal, General Catalyst Partners

Goodwin Procter LLP is one of the nation's leading law firms, with a team of 900 attorneys serving clients through offices in Boston, Hong Kong, London, Los Angeles, New York, San Diego, San Francisco, Silicon Valley and Washington, D.C. The firm's Technology Companies Group is a highly focused team of 160 lawyers who provide dedicated representation to over 500 emerging companies and entrepreneurs, 200 venture capital and private equity firms, and many of the leading investment banks worldwide. Goodwin Procter takes pride in understanding its clients' businesses, shares their entrepreneurial spirit and drive, and provides counsel in connection with venture financings, IPOs, securities offerings, M&A transactions, fund formations and other corporate matters. The firm's areas of industry focus include software, information services, life sciences, cleantech and telecommunications and networking, among others. For more information, please visit www.goodwinprocter.com